Form 8-K - Current report:
SEC Accession No. 0001829126-25-003570
Filing Date
2025-05-12
Accepted
2025-05-12 16:05:28
Documents
13
Period of Report
2025-05-08
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K zeoscientifix_8k.htm   iXBRL 8-K 27820
  Complete submission text file 0001829126-25-003570.txt   195541

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ocel-20250508.xsd EX-101.SCH 2990
3 XBRL LABEL FILE ocel-20250508_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE ocel-20250508_pre.xml EX-101.PRE 22342
15 EXTRACTED XBRL INSTANCE DOCUMENT zeoscientifix_8k_htm.xml XML 3346
Mailing Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314
Business Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314 888-963-7881
Zeo ScientifiX, Inc. (Filer) CIK: 0001557376 (see all company filings)

EIN.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 000-55008 | Film No.: 25934715
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)